{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T05:24:29Z","timestamp":1736832269711,"version":"3.33.0"},"posted":{"date-parts":[[2024,5,30]]},"group-title":"In Review","reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,30]]},"abstract":"<title>Abstract<\/title>\n        <p>Purpose\n The sphingosine-1-phosphate receptor-1 (S1PR<sub>1<\/sub>) is involved in regulating responses to neuroimmune stimuli. There is a need for S1PR<sub>1<\/sub>-specific radioligands with clinically suitable brain pharmcokinetic properties to complement existing radiotracers. This work evaluated a promising S1PR<sub>1<\/sub> radiotracer, [<sup>18<\/sup>F]TZ4877, in nonhuman primates.\nProcedures:\n [<sup>18<\/sup>F]TZ4877 was produced via nucleophilic substitution of tosylate precursor with K[<sup>18<\/sup>F]\/F<sup>\u2212<\/sup> followed by deprotection. Brain PET imaging data were acquired with a Focus220 scanner in two <italic>Macaca mulatta<\/italic> (6, 13 years old) for 120\u2013180 min following bolus injection of 118\u2013163 MBq [<sup>18<\/sup>F]TZ4877, with arterial blood sampling and metabolite analysis to measure the parent input function and plasma free fraction (<italic>f<\/italic><sub>P<\/sub>). Each animal was scanned at baseline, 15\u201318 min after 0.047\u20130.063 mg\/kg of the S1PR<sub>1<\/sub> inhibitor ponesimod, 33 min after 0.4\u20130.8 mg\/kg of the S1PR<sub>1<\/sub>-specific compound TZ82112, and 167\u2013195 min after 1 ng\/kg of the immune stimulus endotoxin. Kinetic analysis with metabolite-corrected input function was performed to estimate the free fraction corrected total distribution volume (<italic>V<\/italic><sub>T<\/sub>\/<italic>f<\/italic><sub>P<\/sub>). Whole-body dosimetry scans were acquired in 2 animals (1M, 1F) with a Biograph Vision PET\/CT System, and absorbed radiation dose estimates were calculated with OLINDA.\nResults\n [<sup>18<\/sup>F]TZ4877 exhibited fast kinetics that were described by the reversible 2-tissue compartment model. Baseline [<sup>18<\/sup>F]TZ4877 <italic>f<\/italic><sub>P<\/sub> was low (&lt;\u20091%), and [<sup>18<\/sup>F]TZ4877 <italic>V<\/italic><sub>T<\/sub>\/<italic>f<\/italic><sub>P<\/sub> values were 233\u2013866 mL\/cm<sup>3<\/sup>. TZ82112 dose-dependently reduced [<sup>18<\/sup>F]TZ4877 <italic>V<\/italic><sub>T<\/sub>\/<italic>f<\/italic><sub>P<\/sub>, while ponesimod and endotoxin exhibited negligible effects on <italic>V<\/italic><sub>T<\/sub>\/<italic>f<\/italic><sub>P<\/sub>, possibly due to scan timing relative to dosing. Dosimetry studies identified the critical organs of gallbladder (0.42 (M) and 0.31 (F) mSv\/MBq) for anesthetized nonhuman primate.\nConclusions\n [<sup>18<\/sup>F]TZ4877 exhibits reversible kinetic properties, but the low <italic>f<\/italic><sub>P<\/sub> value limits quantification with this radiotracer. S1PR<sub>1<\/sub> is a compelling PET imaging target, and these data support pursuing alternative F-18 labeled radiotracers for potential future human studies.<\/p>","DOI":"10.21203\/rs.3.rs-4350862\/v1","type":"posted-content","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T20:16:05Z","timestamp":1717100165000},"source":"Crossref","is-referenced-by-count":0,"title":["PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [18F]TZ4877 in Nonhuman Primates"],"prefix":"10.21203","author":[{"given":"Jiwei","family":"Gu","sequence":"first","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Qiang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Holden","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista","family":"Fowles","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qiu","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Felchner","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Ropchan","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Gropler","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E","family":"Carson","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-1381","authenticated-orcid":false,"given":"Ansel T","family":"Hillmer","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1194\/jlr.R046300","article-title":"An update on the biology of sphingosine 1-phosphate receptors","volume":"55","author":"Blaho VA","year":"2014","unstructured":"Blaho VA, Hla T (2014) An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res 55(8):1596\u20131608","journal-title":"J Lipid Res"},{"issue":"9","key":"ref2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/intimm\/dxz037","article-title":"Sphingosine 1-phosphate and inflammation","volume":"31","author":"Obinata H","year":"2019","unstructured":"Obinata H, Hla T (2019) Sphingosine 1-phosphate and inflammation. Int Immunol 31(9):617\u2013625. 10.1093\/intimm\/dxz037","journal-title":"Int Immunol"},{"issue":"10306","key":"ref3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions","volume":"398","author":"McGinley MP","year":"2021","unstructured":"McGinley MP, Cohen JA (2021) Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions. Lancet 398(10306):1184\u20131194. 10.1016\/S0140-6736(21)00244-0","journal-title":"Lancet"},{"issue":"23","key":"ref4","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.bmcl.2018.10.042","article-title":"An update on sphingosine-1-phosphate receptor 1 modulators","volume":"28","author":"Marciniak A","year":"2018","unstructured":"Marciniak A, Camp SM, Garcia JGN, Polt R (2018) An update on sphingosine-1-phosphate receptor 1 modulators. Bioorg Med Chem Lett 28(23):3585\u20133591. https:\/\/doi.org\/10.1016\/j.bmcl.2018.10.042","journal-title":"Bioorg Med Chem Lett"},{"issue":"7301","key":"ref5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez SE","year":"2010","unstructured":"Alvarez SE, Harikumar KB, Hait NC et al (2010) Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465(7301):1084\u20131088. 10.1038\/nature09128","journal-title":"Nature"},{"issue":"10","key":"ref6","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1074\/jbc.M111423200","article-title":"Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling","volume":"277","author":"Xia P","year":"2002","unstructured":"Xia P, Wang L, Moretti PA et al (2002) Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J Biol Chem 277(10):7996\u20138003. 10.1074\/jbc.M111423200","journal-title":"J Biol Chem"},{"issue":"7","key":"ref7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nn.3728","article-title":"Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory","volume":"17","author":"Hait NC","year":"2014","unstructured":"Hait NC, Wise LE, Allegood JC et al (2014) Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory. Nat Neurosci 17(7):971\u2013980. 10.1038\/nn.3728","journal-title":"Nat Neurosci"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/jnc.14313","article-title":"Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia","volume":"144","author":"O'Sullivan SA","year":"2018","unstructured":"O'Sullivan SA, O'Sullivan C, Healy LM, Dev KK, Sheridan GK (2018) Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia. J Neurochem 144(6):736\u2013747. 10.1111\/jnc.14313","journal-title":"J Neurochem"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Doorn R","year":"2010","unstructured":"Van Doorn R, Van Horssen J, Verzijl D et al (2010) Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions. Glia 58(12):1465\u20131476","journal-title":"Glia"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"e23905","DOI":"10.1371\/journal.pone.0023905","article-title":"Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions","volume":"6","author":"Fischer I","year":"2011","unstructured":"Fischer I, Alliod C, Martinier N, Newcombe J, Brana C, Pouly S (2011) Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS ONE 6(8):e23905","journal-title":"PLoS ONE"},{"issue":"19","key":"ref11","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1021\/acschemneuro.1c00492","article-title":"In Vitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H]CS1P1 and [11C]CS1P1","volume":"12","author":"Jiang H","year":"2021","unstructured":"Jiang H, Joshi S, Liu H et al (2021) In Vitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H]CS1P1 and [11C]CS1P1. ACS Chem Neurosci 12(19):3733\u20133744. 10.1021\/acschemneuro.1c00492","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s11307-016-0944-y","article-title":"PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis","volume":"18","author":"Liu H","year":"2016","unstructured":"Liu H, Jin H, Yue X et al (2016) PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis. Mol Imaging Biol 18(5):724\u2013732 DOI: 10.1007\/s11307-016-0944-y PMID \u2013\u200926975859","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s12350-015-0391-1","article-title":"A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury","volume":"24","author":"Jin H","year":"2017","unstructured":"Jin H, Yang H, Liu H et al (2017) A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury. J Nucl Cardiol 24(2):558\u2013570. 10.1007\/s12350-015-0391-1PMID \u2013\u200926843200","journal-title":"J Nucl Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1536012116689770","DOI":"10.1177\/1536012116689770","article-title":"PET Study of Sphingosine-1-Phosphate Receptor 1 Expression in Response to Vascular Inflammation in a Rat Model of Carotid Injury","volume":"16","author":"Liu H","year":"2017","unstructured":"Liu H, Jin H, Yue X et al (2017) PET Study of Sphingosine-1-Phosphate Receptor 1 Expression in Response to Vascular Inflammation in a Rat Model of Carotid Injury. Mol Imaging 16:1536012116689770 10.1177\/1536012116689770 PMID \u2013\u200928654378","journal-title":"Mol Imaging"},{"author":"Brier MR","key":"ref15","doi-asserted-by":"publisher","unstructured":"Brier MR, Hamdi M, Rajamanikam J et al Phase 1 Evaluation of 11C-CS1P1 to Assess Safety and Dosimetry in Human Participants. J Nucl Med 2022:jnumed.121.263189. 10.2967\/jnumed.121.263189","DOI":"10.2967\/jnumed.121.263189"},{"issue":"5","key":"ref16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1039\/d1ob02225c","article-title":"Radiosynthesis and evaluation of a fluorine-18 radiotracer [18F]FS1P1 for imaging sphingosine-1-phosphate receptor 1","volume":"20","author":"Qiu L","year":"2021","unstructured":"Qiu L, Jiang H, Yu Y et al (2021) Radiosynthesis and evaluation of a fluorine-18 radiotracer [18F]FS1P1 for imaging sphingosine-1-phosphate receptor 1. Org Biomol Chem 20(5):1041\u20131052. 10.1039\/d1ob02225cPMID \u2013\u200935029272","journal-title":"Org Biomol Chem"},{"issue":"5","key":"ref17","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s11307-020-01514-8","article-title":"In vivo Characterization of Four 18F-Labeled S1PR1 Tracers for Neuroinflammation","volume":"22","author":"Liu H","year":"2020","unstructured":"Liu H, Luo Z, Gu J et al (2020) In vivo Characterization of Four 18F-Labeled S1PR1 Tracers for Neuroinflammation. Mol Imaging Biol 22(5):1362\u20131369. 10.1007\/s11307-020-01514-8PMID \u2013\u200932602083","journal-title":"Mol Imaging Biol"},{"issue":"47","key":"ref18","doi-asserted-by":"publisher","first-page":"9171","DOI":"10.1039\/c8ob02609b","article-title":"Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates","volume":"16","author":"Luo Z","year":"2018","unstructured":"Luo Z, Han J, Liu H et al (2018) Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates. Org Biomol Chem 16(47):9171\u20139184. 10.1039\/c8ob02609bPMID \u2013\u200930462126","journal-title":"Org Biomol Chem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9982020","DOI":"10.1155\/2021\/9982020","article-title":"PET Study of Sphingosine-1-phosphate Receptor 1 Expression in Response to <\u2009i\u2009>\u2009S. aureus\u2009Infection","volume":"2021","author":"Jiang H","year":"2021","unstructured":"Jiang H, Gu J, Zhao H et al (2021) PET Study of Sphingosine-1-phosphate Receptor 1 Expression in Response to <\u2009i\u2009>\u2009S. aureus\u2009Infection. Mol Imaging 2021:9982020. 10.1155\/2021\/9982020","journal-title":"Mol Imaging"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0969-8051(00)00125-6","article-title":"Column-switching HPLC for the analysis of plasma in PET imaging studies","volume":"27","author":"Hilton J","year":"2000","unstructured":"Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF (2000) Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol 27(6):627\u2013630. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11056380","journal-title":"Nucl Med Biol"},{"issue":"Supplement 1","key":"ref21","first-page":"2320","article-title":"Synthesis and initial in vivo evaluation of F-18 radioligands for S1PR1 PET imaging","volume":"64","author":"Qiu L","year":"2022","unstructured":"Qiu L, Jiang H, Wang J et al (2022) Synthesis and initial in vivo evaluation of F-18 radioligands for S1PR1 PET imaging. J Nucl Med 64(Supplement 1):2320","journal-title":"J Nucl Med"},{"issue":"1","key":"ref22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13550-017-0305-0","article-title":"Microglial depletion and activation: A [11C]PBR28 PET study in nonhuman primates","volume":"7","author":"Hillmer AT","year":"2017","unstructured":"Hillmer AT, Holden D, Fowles K et al (2017) Microglial depletion and activation: A [11C]PBR28 PET study in nonhuman primates. EJNMMI Res 7(1):59 (In eng). 10.1186\/s13550-017-0305-0","journal-title":"EJNMMI Res"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroimage.2012.06.055","article-title":"Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates","volume":"63","author":"Hannestad J","year":"2012","unstructured":"Hannestad J, Gallezot JD, Schafbauer T et al (2012) Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates. NeuroImage 63(1):232\u2013239 (In eng). 10.1016\/j.neuroimage.2012.06.055","journal-title":"NeuroImage"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neuroimage.2012.08.051","article-title":"Optimization of PET-MR registrations for nonhuman primates using mutual information measures: a Multi-Transform Method (MTM)","volume":"64","author":"Sandiego CM","year":"2013","unstructured":"Sandiego CM, Weinzimmer D, Carson RE (2013) Optimization of PET-MR registrations for nonhuman primates using mutual information measures: a Multi-Transform Method (MTM). NeuroImage 64:571\u2013581 (In eng). 10.1016\/j.neuroimage.2012.08.051","journal-title":"NeuroImage"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fninf.2012.00027","article-title":"The INIA19 Template and NeuroMaps Atlas for Primate Brain Image Parcellation and Spatial Normalization","volume":"6","author":"Rohlfing T","year":"2012","unstructured":"Rohlfing T, Kroenke CD, Sullivan EV et al (2012) The INIA19 Template and NeuroMaps Atlas for Primate Brain Image Parcellation and Spatial Normalization. Front Neuroinform 6:27. 10.3389\/fninf.2012.00027","journal-title":"Front Neuroinform"},{"issue":"9","key":"ref26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis RB","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J et al (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27(9):1533\u20131539 (In eng). 10.1038\/sj.jcbfm.9600493","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"ref27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","article-title":"Positron emission tomography compartmental models","volume":"21","author":"Gunn RN","year":"2001","unstructured":"Gunn RN, Gunn SR, Cunningham VJ (2001) Positron emission tomography compartmental models. J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism 21(6):635\u2013652 (In eng). 10.1097\/00004647-200106000-00002","journal-title":"J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/biomet\/76.2.297","article-title":"Regression and time series model selection in small samples","volume":"76","author":"Hurvich CM","year":"1989","unstructured":"Hurvich CM, Tsai C-L (1989) Regression and time series model selection in small samples. Biometrika 76(2):297\u2013307","journal-title":"Biometrika"},{"issue":"10","key":"ref29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/00004647-200210000-00015","article-title":"Strategies to improve neuroreceptor parameter estimation by linear regression analysis","volume":"22","author":"Ichise M","year":"2002","unstructured":"Ichise M, Toyama H, Innis RB, Carson RE (2002) Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism 22(10):1271\u20131281 (In eng). 10.1097\/00004647-200210000-00015","journal-title":"J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/jcbfm.2009.190","article-title":"Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited","volume":"30","author":"Cunningham VJ","year":"2010","unstructured":"Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN (2010) Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism 30(1):46\u201350 (In eng). 10.1038\/jcbfm.2009.190","journal-title":"J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism"},{"key":"ref31","volume-title":"Specific absorbed fractions of energy at various ages from internal photon sources","author":"Cristy M","year":"1981","unstructured":"Cristy M (1981) Specific absorbed fractions of energy at various ages from internal photon sources. ORNL-TM-8381"},{"issue":"6","key":"ref32","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin MG","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E (2005) OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46(6):1023\u20131027","journal-title":"J Nucl Med"},{"issue":"2","key":"ref33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","article-title":"Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects","volume":"81","author":"Chun J","year":"2021","unstructured":"Chun J, Giovannoni G, Hunter SF (2021) Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects. Drugs 81(2):207\u2013231. 10.1007\/s40265-020-01431-8","journal-title":"Drugs"},{"issue":"16","key":"ref34","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1080\/14656566.2020.1799977","article-title":"Ponesimod for the treatment of relapsing multiple sclerosis","volume":"21","author":"Baldin E","year":"2020","unstructured":"Baldin E, Lugaresi A (2020) Ponesimod for the treatment of relapsing multiple sclerosis. Expert Opin Pharmacother 21(16):1955\u20131964. 10.1080\/14656566.2020.1799977","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"ref35","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1021\/acs.jmedchem.2c01752","article-title":"Discovery of a Promising Fluorine-18 Positron Emission Tomography Radiotracer for Imaging Sphingosine-1-Phosphate Receptor 1 in the Brain","volume":"66","author":"Qiu L","year":"2023","unstructured":"Qiu L, Jiang H, Zhou C et al (2023) Discovery of a Promising Fluorine-18 Positron Emission Tomography Radiotracer for Imaging Sphingosine-1-Phosphate Receptor 1 in the Brain. J Med Chem 66(7):4671\u20134688. 10.1021\/acs.jmedchem.2c01752","journal-title":"J Med Chem"},{"year":"2012","author":"Aslanis V","key":"ref36","unstructured":"Aslanis V, Faller T, Van De Kerkhof E, Schubart A, Wallstr\u00f6m E, Beyerbach A (2012) Siponimod (BAF312) (and\/or its metabolites) penetrates into the CNS and distributes to white matter areas. Mult Scler J. ;18:279\u2013508. (https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-85044616677&partnerID=40&md5=3f301c00e87bf1864239b0e20c99e286)"},{"issue":"2","key":"ref37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis","volume":"323","author":"Foster CA","year":"2007","unstructured":"Foster CA, Howard LM, Schweitzer A et al (2007) Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis. J Pharmacol Exp Ther 323(2):469\u2013475. 10.1124\/jpet.107.127183","journal-title":"J Pharmacol Exp Ther"},{"issue":"40","key":"ref38","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1073\/pnas.1511003112","article-title":"Imaging robust microglial activation after lipopolysaccharide administration in humans with PET","volume":"112","author":"Sandiego CM","year":"2015","unstructured":"Sandiego CM, Gallezot J-D, Pittman B et al (2015) Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci USA 112(40):12468\u201312473","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ejmech.2018.03.035","article-title":"Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents","volume":"150","author":"Luo Z","year":"2018","unstructured":"Luo Z, Rosenberg AJ, Liu H, Han J, Tu Z (2018) Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents. Eur J Med Chem 150:796\u2013808. https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.035","journal-title":"Eur J Med Chem"},{"issue":"13","key":"ref40","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1021\/acs.jmedchem.6b00390","article-title":"Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer","volume":"59","author":"Rosenberg AJ","year":"2016","unstructured":"Rosenberg AJ, Liu H, Jin H et al (2016) Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer. J Med Chem 59(13):6201\u20136220. 10.1021\/acs.jmedchem.6b00390","journal-title":"J Med Chem"},{"issue":"5","key":"ref41","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1172\/JCI71194","article-title":"Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo","volume":"124","author":"Kono M","year":"2014","unstructured":"Kono M, Tucker AE, Tran J, Bergner JB, Turner EM, Proia RL (2014) Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo. J Clin Investig 124(5):2076\u20132086. 10.1172\/JCI71194","journal-title":"J Clin Investig"},{"issue":"2","key":"ref42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/j.semnuclmed.2022.08.008","article-title":"Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies","volume":"53","author":"Raval NR","year":"2023","unstructured":"Raval NR, Wetherill RR, Wiers CE, Dubroff JG, Hillmer AT (2023) Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies. Semin Nucl Med 53(2):213\u2013229. https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.08.008","journal-title":"Semin Nucl Med"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13550-020-00670-w","article-title":"Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand 11C-UCB-J","volume":"10","author":"Bini J","year":"2020","unstructured":"Bini J, Holden D, Fontaine K et al (2020) Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand 11C-UCB-J. EJNMMI Res 10(1):83. 10.1186\/s13550-020-00670-w","journal-title":"EJNMMI Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4350862\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4350862\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T16:15:19Z","timestamp":1736784919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4350862\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":43,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4350862\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s11307-024-01979-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,5,30]]},"subtype":"preprint"}}